ADMA BIOLOGICS, INC. annual report, Q2 FY2011

Business Context and Reporting Period

Company: R&R Acquisition VI, Inc. (Note: Metadata listed "ADMA BIOLOGICS, INC." but the filing text identifies the registrant as R&R Acquisition VI, Inc.)
Reporting Period: Fiscal year ended June 30, 2011
Business Type: Development stage "blank check" company and shell company.
Objective: To investigate and acquire a target company to achieve long-term growth potential. The company has no specific business plan, no employees, and no material assets other than cash. It is not currently engaged in any revenue-generating operations.

Key Financial Metrics

Metric 2011 2010
Revenue $0 $0
Total Operating Expenses $26,464 $20,530
Net Loss $(26,460) $(20,526)
Cash and Cash Equivalents $8,512 $12,012
Working Capital $(1,306) $(346)
Accrued Expenses (Liabilities) $9,818 $12,358
Stockholders' Equity (Deficit) $(1,306) $(346)

Liquidity: The company relies on capital contributions and loans from stockholders and management. Cash on hand ($8,512) is intended to cover expenses for the next 12 months, though there is no assurance of future funding.

Material Changes vs. Prior Period

  • Expenses: Total operating expenses increased by approximately 29% from $20,530 in 2010 to $26,464 in 2011. This increase is attributed to higher professional and administrative fees.
  • Cash Position: Cash decreased by $3,500 (from $12,012 to $8,512) due to net cash used in operating activities of $29,000, partially offset by $25,500 in contributed capital.
  • Liabilities: Accrued expenses decreased by $2,540, indicating some payment of prior obligations.
  • Equity: Additional paid-in capital increased by $25,500 due to a capital contribution from a stockholder during the fiscal year.

Outlook, Risks, and Management Commentary

  • Outlook: Management plans to locate a suitable acquisition or merger candidate over the next 12 months. No definitive agreements exist with any prospective targets. Success is entirely dependent on consummating a business combination.
  • Risks:
    • Going Concern: The company has no operating history and sustains losses. There is a risk it cannot continue as a going concern without a merger or additional financing.
    • Competition: Faces significant competition from better-financed entities for potential acquisition targets.
    • Management Time: Officers devote less than 10% of their time to the company, which may delay identifying a target.
    • Dilution: Future mergers may result in substantial dilution to existing shareholders through the issuance of additional shares.
    • Conflicts of Interest: Management is involved with other blank check companies and may receive compensation from target companies.
  • Unusual Items: The company is a shell company with no public trading market for its stock. It has never paid dividends and does not intend to do so.

Investor Verification Checklist

  • Capital Adequacy: Verify if the current cash balance ($8,512) is sufficient to maintain SEC reporting compliance for the next 12 months without further stockholder contributions.
  • Related Party Transactions: Confirm the terms of the office occupancy agreement with Kirk M. Warshaw, LLC (an affiliate of the CFO) and the source of the $25,500 capital contribution.
  • Management Commitment: Assess the impact of officers devoting less than 10% of their time to the company on the likelihood of finding a merger target.
  • Stock Ownership: Note that R&R Investments VI, LLC controls 80% of the outstanding shares, giving them significant control over merger decisions.
  • Accrued Liabilities: Investigate the nature of the $9,818 in accrued expenses to ensure no hidden obligations exist.